Premium Nahrungsergänzungsmittel | artgerecht

Bile Acid Receptor – Function and Clinical Role

The bile acid receptor is a cellular receptor that responds to bile acids and regulates key metabolic processes in the liver, intestine, and other organs.

Regular tips about health Regular tips about health

Things worth knowing about "Bile Acid Receptor"

The bile acid receptor is a cellular receptor that responds to bile acids and regulates key metabolic processes in the liver, intestine, and other organs.

What Is the Bile Acid Receptor?

The bile acid receptor is a specialized protein located on or inside cells that recognizes and binds bile acids. Bile acids are endogenous molecules synthesized in the liver from cholesterol and secreted into bile. They play a central role in the digestion of dietary fats in the intestine. However, through their receptors, bile acids exert effects far beyond digestion: they regulate glucose and lipid metabolism, modulate the immune system, and influence the overall energy balance of the body.

The Major Bile Acid Receptors

Several types of bile acid receptors exist, located in different tissues and performing distinct functions:

FXR (Farnesoid X Receptor)

The Farnesoid X Receptor (FXR) is the best-known and most thoroughly studied bile acid receptor. It belongs to the nuclear receptor superfamily and resides in the cell nucleus. FXR is expressed predominantly in the liver, small intestine, kidney, and adrenal glands. Upon bile acid binding, FXR regulates the expression of numerous genes encoding enzymes and transport proteins involved in bile acid metabolism, lipid processing, and glucose homeostasis. Activation of FXR inhibits the de novo synthesis of bile acids in the liver, preventing toxic accumulation.

TGR5 (Takeda G-Protein-Coupled Receptor 5)

TGR5 (also known as GPBAR1) is a G-protein-coupled receptor located on the cell surface. It is found in gallbladder epithelial cells, the intestine, brown adipose tissue, the liver, and the central nervous system. TGR5 promotes the release of the gut hormone GLP-1 (glucagon-like peptide-1), which stimulates insulin secretion and lowers blood glucose levels. In addition, TGR5 activation increases energy expenditure by enhancing thermogenesis.

Other Bile Acid Receptors

Beyond FXR and TGR5, additional receptors respond to bile acids, including S1P2 (sphingosine-1-phosphate receptor 2), M2 muscarinic acetylcholine receptors, and the vitamin D receptor (VDR), which can be activated by the secondary bile acid derivative lithocholic acid.

Biological Functions

Bile acid receptors fulfill a wide range of physiological roles:

Regulation of bile acid metabolism: FXR suppresses de novo bile acid synthesis in the liver and promotes their elimination, preventing toxic concentrations.
Lipid metabolism: FXR activates genes that control the transport and breakdown of triglycerides and cholesterol.
Glucose metabolism: Both FXR and TGR5 improve insulin sensitivity and support blood glucose control.
Energy metabolism: TGR5 enhances thermogenesis in brown adipose tissue, thereby increasing basal metabolic rate.
Regulation of inflammation: FXR exhibits anti-inflammatory properties and helps maintain the integrity of the intestinal barrier.
Gut-liver axis: Bile acid receptors mediate communication between the gut and the liver, partly involving the gut microbiome.

Clinical Relevance

Dysregulation of bile acid receptor signaling is associated with several diseases:

Non-alcoholic fatty liver disease (NAFLD) and liver cirrhosis: Reduced FXR activity promotes hepatic fat accumulation and inflammatory processes.
Type 2 diabetes and metabolic syndrome: Bile acid receptors substantially influence glucose and lipid metabolism.
Cholestasis: Impaired bile acid flow leads to toxic accumulation of bile acids, causing cell damage.
Intestinal diseases: Dysregulation of bile acid signaling has been linked to inflammatory bowel disease and irritable bowel syndrome.
Atherosclerosis and cardiovascular disease: Since bile acid receptors regulate cholesterol metabolism, they influence cardiovascular risk.

Therapeutic Applications

Growing understanding of bile acid receptors has led to the development of new therapeutic agents:

Obeticholic acid (OCA): A synthetic FXR agonist approved for the treatment of primary biliary cholangitis (PBC) and under investigation in clinical trials for NAFLD/NASH.
Bile acid sequestrants: Medications such as cholestyramine indirectly modulate bile acid signaling by binding bile acids in the intestine and preventing their reabsorption.
TGR5 agonists: Currently in preclinical and clinical research for the treatment of type 2 diabetes and obesity.

References

Forman B.M. et al. - Identification of a nuclear receptor that is activated by farnesol metabolites. Cell, 81(5):687-693 (1995). PubMed PMID: 7774010.
Kawamata Y. et al. - A G protein-coupled receptor responsive to bile acids. Journal of Biological Chemistry, 278(11):9435-9440 (2003). PubMed PMID: 12524422.
European Medicines Agency (EMA) - Assessment Report: Ocaliva (obeticholic acid). EMA/CHMP/688951/2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.